NCT00288600View on ClinicalTrials.gov

Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

August 31, 2010

Conditions

HyperbilirubinemiaErythroblastosis, Fetal

Interventions

DRUG

Intravenous Immunoglobulin

DRUG

Normal saline solution

Normal saline solution 10 ml/Kg

Trial Locations (1)

22420040

Maria Elisabeth L Moreira, Rio de Janeiro

All Listed Sponsors

collaborator

Instituto Fernandes Figueira

OTHER_GOV

lead

Oswaldo Cruz Foundation

OTHER

NCT00288600 - Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease | Biotech Hunter | Biotech Hunter